title: Pharmaceutical Approval Update.
abstract: Olaratumab (Lartruvo) for the treatment of soft tissue sarcoma; bezlotoxumab (Zinplava) for use with an antibiotic to reduce recurrence ofC. difficileinfection; and doxylamine succinate/pyridoxine hydrochloride (Bonjesta) for the treatment of nausea and vomiting during pregnancy.
authors.forename: Mary
authors.initials: M
authors.lastname: Choy